The UK Parliament voted on 15th January 2019 rejecting the EU/UK Brexit deal and therefore, a number of unknown variables regarding the current Brexit situation remain.
Watch PCI Clinical Services and their partners for this educational webinar to learn more the specific considerations required for Phase I trial design in Australia. You’ll also discover Australia’s R&D tax incentive program and...
PCI Clinical Services and our Guests discuss Brexit and its impact on Clinical Trials in the EU and UK
PCI Pharma Services has invested in state-of-the-art containment equipment and created a ‘Potent Passport’ philosophy to identify the specific handling requirements for any Highly Potent Active Pharmaceutical Ingredients...
The need for clinical trials to meet the requirements of regulators, deliver high-quality data, and come in on budget has led to study designs that focus on timeliness and convenience, yet may unduly burden and...
Watch the Bridgend expansion unfold in this stop motion video.
When it comes to pharmaceutical and biopharmaceutical supply chain expertise who do you trust?
Start your PCI experience today.Your bridge between life-changing therapies and patients.
